logo
Future-Proofing EV Charging Infrastructure: Verdek Completes Installation in Austin, TX

Future-Proofing EV Charging Infrastructure: Verdek Completes Installation in Austin, TX

MONROE, Conn., March 28, 2025 /PRNewswire/ -- Verdek LLC proudly announces the successful and on-time completion of a state-of-the-art EV charging infrastructure project in Austin, Texas. This milestone project, characterized by innovative solutions and meticulous execution, underscores Verdek's commitment to sustainability, efficiency, and future-ready infrastructure.
A Vision for the Future
The project lays the groundwork for a scalable EV charging network, featuring the installation of Level 2 and DC fast charging stations, with infrastructure prepared for an additional stations. In anticipation of future upgrades, Verdek strategically upscaled conduits to accommodate future potential installations, ensuring seamless expansion as EV adoption continues to grow. These future-proofing measures mitigate the need for disruptive and costly modifications in the future.
Efficiency, Cost-Effectiveness, and On-Time Delivery
Verdek's project management approach prioritized efficiency, cost-effectiveness, and strict adherence to deadlines. Through strategic planning and optimized resource allocation, the team successfully completed the installation on schedule and within budget, despite the complexities of site preparation and infrastructure expansion. By incorporating scalable design elements, Verdek minimized long-term maintenance and upgrade costs, providing exceptional value to our esteemed client and its stakeholders.
Future-Ready and Environmentally Conscious
'Our team has successfully delivered a project that exemplifies the balance between innovation, operational efficiency, and environmental stewardship—all while meeting our strict project timeline,' said Guy Mannino, CEO of Verdek LLC. 'The site in Austin now serves as a model for cost-effective, scalable EV charging infrastructure. We are proud to contribute to a cleaner, more sustainable future with this initiative.'
About Verdek: With over 16+ years of experience in delivering cutting-edge EV charging solutions, Verdek has established itself as a trusted partner for businesses, municipalities, and government entities nationwide. The company's expertise in integrating advanced technology with user-centric design has consistently set new industry standards. A notable example of Verdek's capabilities is its eBus charging infrastructure in New York City. As a premier provider of electric vehicle charging solutions, Verdek is committed to fostering the growth of sustainable transportation. Offering a comprehensive range of products and services, the company delivers innovative, reliable, and user-friendly charging solutions tailored to meet the diverse needs of customers across North America. For more information, please contact us at [email protected] or (888) 336-3734. Visit us at www.verdek.com.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Phase-2 Matawinie Mine edges closer to FID
Phase-2 Matawinie Mine edges closer to FID

Yahoo

timean hour ago

  • Yahoo

Phase-2 Matawinie Mine edges closer to FID

Nouveau Monde Graphite (NMG) is making significant strides in advancing its Phase-2 Matawinie Mine and Bécancour Battery Material Plant towards a final investment decision (FID). This progress comes amidst a backdrop of increased electric vehicle (EV) adoption and energy storage demand, positioning NMG favourably in the North American market. The Phase-2 Matawinie Mine is undergoing detailed engineering, contract negotiations and preparation for construction tenders to align with project financing activities. NMG is also working on key environmental infrastructure at the demonstration mining site for additional flake production. Concurrently, the company is focusing on engineering at the Phase-2 Bécancour Battery Material Plant, with support from specialised Asian companies. Large-scale testing at partnering facilities is planned to fine-tune processing technologies and inform commercialisation strategies. These steps are crucial for reaching FID and launching construction. NMG is actively engaging with customers, potential lenders and institutional investors to secure bankable offtake agreements and strategic investments. The company has received letters of interest for more than $1bn (C$1.38bn) in debt financing for the Phase-2 projects, with contributions expected from governmental bodies, public institutions and export credit agencies like Export Development Canada and Canada Infrastructure Bank. NMG's proactive approach to project development and financing, coupled with the favourable market conditions due to the US Department of Commerce's duties on Chinese graphite materials, positions the company to capitalise on the growing demand for EVs and energy storage solutions. NMG founder, president and CEO Eric Desaulniers said: "Resource nationalism, tariffs, policy headwinds and shifting global alliances are creating uncertainty in global supply chains and investment planning. "Nevertheless, we remain centred on our mission to develop a responsible and resilient North American graphite value chain for the battery sector to help meet the expansion of the electric vehicle and energy storage markets. We are refining our execution plan to capitalise on positive political and commercial interests, while reducing vulnerabilities associated with uncertainties." "Phase-2 Matawinie Mine edges closer to FID" was originally created and published by Mining Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

JETSET Pilates Sets Sights on Chicagoland as Next Hot Market for Franchise Growth
JETSET Pilates Sets Sights on Chicagoland as Next Hot Market for Franchise Growth

Yahoo

timean hour ago

  • Yahoo

JETSET Pilates Sets Sights on Chicagoland as Next Hot Market for Franchise Growth

With studios planned for Naperville and Winnetka, the fast-growing Pilates franchise eyes strategic expansion in top Chicago neighborhoods MIAMI, Aug. 18, 2025 /PRNewswire/ -- JETSET Pilates, a fast-growing modern Reformer Pilates franchise offering premium, full-body workouts, is ramping up its Chicagoland expansion with two initial locations confirmed in Naperville and Winnetka, and plans to strategically open 10–12 studios across the region over the next several years. The brand is actively targeting premier neighborhoods in and around Chicago, including Lincoln Park, River North, and the Gold Coast, as well as affluent suburbs such as Evanston, Oak Brook, and Hinsdale. With Chicago ranking #8 on the 2024 Mindbody + ClassPass Wellness Index as one of the nation's healthiest cities, JETSET is poised to meet the region's strong appetite for high-end workout concepts. "Chicago is a city that thrives on innovation, style, and energy, and that's exactly what JETSET delivers," said Bert Albertse, CEO of JETSET Pilates. "From our curated playlists to our studio design, every detail is built to inspire. We see a clear opportunity to make JETSET a go-to fitness destination here, and we're ready to grow alongside the city's community." JETSET's record-setting growth in 2025 includes the opening of 16 new studios in the first half of the year, entry into new U.S. markets, and its first international location in Melbourne, Australia. With more than 160 locations sold and in development, the brand continues to attract interest from franchise partners in top-tier markets like Chicago. "Launching new locations in Naperville and Winnetka is just the beginning," said Tamara Galinsky, Founder and Brand President of JETSET Pilates. "We're actively seeking passionate franchise partners in Chicagoland who share our vision of delivering a premium Pilates experience that meets the city's growing demand for innovative fitness solutions." Since launching its franchise opportunity in 2022, JETSET Pilates has quickly become one of the fastest-growing concepts in the boutique fitness sector. For more information about JETSET Pilates and its franchise opportunities, visit About JETSET Pilates Founded in 2010 and franchising since 2022, JETSET Pilates has rapidly established itself as one of the most attractive concepts in the boutique franchise business space. JETSET Pilates currently has plans to open studios across the U.S. and Australia, with 160 studios in development. JETSET now offers franchising opportunities to entrepreneurs in some of the largest and fastest-growing markets within the fitness franchise sector. For more information, please visit or follow JETSET Pilates on LinkedIn and Instagram. Contact: Elise Fricilone | Franchise Elevator | efricilone@ View original content to download multimedia: SOURCE JETSET Pilates Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Nuclear Medicine Equipment Market worth $8.31 billion by 2030 with 4.62% CAGR
Nuclear Medicine Equipment Market worth $8.31 billion by 2030 with 4.62% CAGR

Yahoo

timean hour ago

  • Yahoo

Nuclear Medicine Equipment Market worth $8.31 billion by 2030 with 4.62% CAGR

DELRAY BEACH, Fla., Aug. 18, 2025 /PRNewswire/ -- The global Nuclear Medicine Equipment Market, valued at US$6.33 billion in 2024, stood at US$6.63 billion in 2025 and is projected to advance at a resilient CAGR of 4.62% from 2025 to 2030, culminating in a forecasted valuation of US$8.31 billion by the end of the period. The growth of this market is primarily accelerated by the increasing prevalence of cancer and cardiovascular diseases, rising demand for early and precise diagnostic imaging, and increased use of hybrid imaging devices such as PET/CT and SPECT/CT. Moreover, the convergence of AI-based imaging software and the establishment of nuclear medicine facilities in emerging economies is creating new platforms for long-term market development. Download PDF Brochure: Browse in-depth TOC on "Nuclear Medicine Equipment Market" 389 - Tables50 - Figures356 - Pages By product type, the nuclear medicine software segment is the fastest growing in the nuclear medicine equipment market. This is attributed to the increasing adoption of theragnostic-based treatment approaches, which require specialized software for personalized dosimetry, real-time treatment response monitoring, and advanced image fusion, especially in oncology applications involving radioligand therapies like ^177Lu-PSMA and ^177Lu-DOTATATE. The need for specialized software tools is also being accelerated by regulatory changes like the Dosimetry Initiative of the SNMMI and the European Council Directive 2013/59/Euratom, which requires customized treatment planning. Additionally, vendors are implementing AI-powered features that facilitate kinetic modeling, quantitative evaluation, and lesion segmentation, which are quickly becoming crucial in busy cancer clinics and research facilities. By Therapeutic Area, this is due to the rising global prevalence of cancer, estimated to be more than 20 million new cases in 2022 and 35 million by 2050, which has significantly increased demand for early, precise, and functional imaging. Nuclear imaging techniques such as PET/CT and SPECT/CT are essential for cancer detection, staging, treatment planning, and response assessment. In addition, the increasing demand for radioligand therapies like ^177Lu-PSMA in prostate cancer and ^177Lu-DOTATATE in neuroendocrine tumors has increased the demand for advanced imaging systems and oncology-specific software. Innovation in the field of radiopharmaceuticals, regulatory backing for theranostics, and increasing reimbursement for cancer diagnostics have also helped dominate the market for this segment. By geography, this is due to the high-level healthcare infrastructure in the region, extensive use of hybrid imaging modalities like PET/CT and SPECT/CT, and high emphasis on early disease detection and individualized medicine. The US alone performs close to 20 million nuclear medicine procedures every year due to the high incidence of cancer and cardiovascular disease. Moreover, the lucrative reimbursement schemes, large investments in nuclear medicine research, and prominent industry players such as GE Healthcare and Siemens Healthineers are supporting sustained market dominance. Government support for theranostic applications and ongoing clinical trials in radiopharmaceutical treatments further cemented the dominant position of North America. Request Sample Pages : The report profiles key players such as Hermes Medical Solutions (Sweden), DOSIsoft (France), Segami Corporation (US), GE HealthCare (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), and Canon Medical Systems Corporation (Japan). GE HealthCare (US): A global medical technology company became an independent publicly traded entity in January 2023 following its separation from General Electric. The company operates through five main business segments, with its nuclear medicine equipment included under the Imaging segment. It combines SPECT and PET imaging systems with software platforms like Xeleris and AI-powered tools for image reconstruction and workflow support. In 2024, GE HealthCare acquired MIM Software to expand its molecular imaging and radiation oncology capabilities, which included image analysis and quantification tools used in clinical settings such as oncology, cardiology, and neurology. With over 50 manufacturing and R&D facilities, GE HealthCare serves hospitals, diagnostic centers, and research institutions in more than 160 countries. Siemens Healthineers AG (Germany) A prominent medical technology company provides a wide range of products and solutions in laboratory diagnostics, healthcare IT, and diagnostic and therapeutic imaging. Its portfolio, which serves hospitals, diagnostic labs, outpatient clinics, and academic institutions globally, includes MRI, CT, PET, SPECT systems, laboratory automation technologies, and cutting-edge digital tools for clinical decision support. The company's nuclear medicine products are under the Imaging segment, specifically under Molecular Imaging, of its four primary business segments: Imaging, Diagnostics, Varian (Advanced Therapies), and Services. It is known for its high-end PET/CT and SPECT/CT systems, which include flagship products such as Biograph PET/CT and Biograph mMR PET/MR hybrids. These systems are complemented by software platforms such as MI Applications and Syngo Via, which facilitate workflow optimization, image quantification, and hybrid imaging through automation and multimodality integration. Nuclear medicine departments, oncology and cardiology clinics, and research institutions use these solutions extensively in oncology, neurology, and cardiac imaging. It has a significant global presence in the medical imaging market due to its operations in more than 70 countries and global manufacturing footprint in Europe, the Americas, and Asia Pacific. For more information, Inquire Now! Related Reports: Radiation Detection, Monitoring & Safety Market Nuclear Medicine Market Electroceuticals Market Diagnostic Imaging Market Medical Radiation Detection Market Get access to the latest updates on Nuclear Medicine Equipment Companies and Nuclear Medicine Equipment Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store